Skeptics of prescription weight-loss medications say that these drugs may not be the quick fix that many people hope for.

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

A healthy high protein prepared meal including chicken, carrots, fruits and greens. Taking Wegovy (semaglutide) can be a ...

Semaglutide is sold as Wegovy for weight-loss and Ozempic for diabetes. At 72 weeks, 37% of patients on the drug showed improvement in liver scarring, with no worsening of steatohepatitis ...

Once-weekly, subcutaneous semaglutide 2.4 mg is marketed under the brand name Wegovy. Part 1 of the ESSENCE trial evaluated the effect of once-weekly semaglutide 2.4 mg on liver tissue (histology ...

Novo Nordisk’s weight loss drug Wegovy helped people with a fatty liver disease called MASH experience improvements in liver scarring and achieve symptom resolution, results the company sees as ...

Novo Nordisk’s drug helped reduce knee pain in osteoarthritis patients with obesity. Meanwhile, the Change Healthcare breach ...

After facing a significant shortage, two highly sought-after weight loss medications, Ozempic and Wegovy, are once again available, as confirmed by a government drug shortage tracker. Novo Nordisk ...

Oct 30 (Reuters) - The lowest dose of Novo Nordisk's (NOVOb.CO), opens new tab weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on Wednesday. Several doses ...